Split-Trp (or protein fragment complementation assay) requires a tryptophan biosynthetic pathway, which is present in mycobacteria. It relies on the reconstitution of an active Trp1p enzyme, only if the POIs interact with each other (Figure 4 and Table 1). This will then allow the tryptophan auxotrophic strain of M. smegmatis ΔhisA to grow on media without tryptophan [83]. The validity of split-Trp was assessed by confirming interactions between ESAT-6 and CFP-10, and the homodimerization of GlfT1 and RegX3 [83]. In parallel with M-PFC, split-Trp was used to evaluate interactions between PknH and DosR. However, only the phosphorylation-defective form of DosR (T198A/T205A) was able to interact with PknH in this system, suggesting that split-Trp is less sensitive than M-PFC [79].
Schematic representation of the split-Trp (or protein fragment complementation assay) technology.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.